Proteome Sciences plc (LON:PRM – Get Free Report)’s share price shot up 9% on Monday . The stock traded as high as GBX 3.91 ($0.05) and last traded at GBX 3.35 ($0.04). 967,070 shares traded hands during mid-day trading, an increase of 496% from the average session volume of 162,146 shares. The stock had previously closed at GBX 3.07 ($0.04).
Proteome Sciences Stock Up 9.0 %
The firm has a market capitalization of £9.89 million, a PE ratio of -335.00 and a beta of 0.07. The firm’s 50-day moving average price is GBX 2.72 and its two-hundred day moving average price is GBX 3.15.
About Proteome Sciences
Proteome Sciences plc provides contract research services for the identification, validation, and application of protein biomarkers in the United States, the United Kingdom, European Union, and internationally. The company offers TMT LC-MS2, a standard method for analyzing cells and tissues when no phosphopeptide enrichment is required; TMT LC-MS3, a standard method for biomarker discovery in plasma and other samples where quantitative accuracy is a factor; SysQuant, provides an analysis of protein activity across regulatory and signaling pathways; and TMTcalibrator, analyzes where diseased or treated tissue can be analyzed in parallel with peripheral fluids.
Recommended Stories
- Five stocks we like better than Proteome Sciences
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- Dow Jones: A Relevant Benchmark or a Relic of the Past?
- What is a Stock Market Index and How Do You Use Them?
- 3 Big-Name Stocks Just Announced Big-Time Dividend Increases
- The Top 3 Healthcare Dividend Stocks to Buy and Hold
- Market Overreaction: 2 Stocks to Buy on the Way Down
Receive News & Ratings for Proteome Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Proteome Sciences and related companies with MarketBeat.com's FREE daily email newsletter.
